{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T11:03:24Z","timestamp":1774004604207,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274150"],"award-info":[{"award-number":["82274150"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82374322"],"award-info":[{"award-number":["82374322"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304900"],"award-info":[{"award-number":["82304900"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.isci.2025.114359","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T08:26:19Z","timestamp":1765355179000},"page":"114359","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["p38 inhibition restores chemosensitivity of tumor cells by disrupting oligomerized breast cancer resistance protein membrane trafficking"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1734-4670","authenticated-orcid":false,"given":"Yanhong","family":"Pan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunxuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tongyao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suyun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhonghong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiyun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4571-7622","authenticated-orcid":false,"given":"Wenxing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2025.114359_bib1","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.canlet.2017.02.027","article-title":"Resistance to metronomic chemotherapy and ways to overcome it","volume":"400","author":"Riesco-Martinez","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.isci.2025.114359_bib2","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.3390\/ijms21093233","article-title":"Mechanisms of Multidrug Resistance in Cancer Chemotherapy","volume":"21","author":"Bukowski","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2025.114359_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108488","article-title":"Strategies to overcome cancer multidrug resistance (MDR) through targeting P-glycoprotein (ABCB1): An updated review","volume":"249","author":"Dong","year":"2023","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.isci.2025.114359_bib4","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.chembiol.2024.11.009","article-title":"The efflux pump ABCC1\/MRP1 constitutively restricts PROTAC sensitivity in cancer cells","volume":"32","author":"Wolf","year":"2025","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.isci.2025.114359_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2024.119878","article-title":"The association of ABC proteins with multidrug resistance in cancer","volume":"1872","author":"Marques","year":"2025","journal-title":"Biochim. Biophys. Acta. Mol. Cell Res."},{"key":"10.1016\/j.isci.2025.114359_bib6","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1080\/07391102.2020.1855249","article-title":"Study on reversal of ABCB1 mediated multidrug resistance in Colon cancer by acetogenins: An in-silico approach","volume":"40","author":"Jeevitha Priya","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.isci.2025.114359_bib7","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.fct.2017.03.024","article-title":"Resveratrol as MDR reversion molecule in breast cancer: An overview","volume":"103","author":"Alamolhodaei","year":"2017","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.isci.2025.114359_bib8","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.3390\/molecules25153364","article-title":"Overcoming Multidrug Resistance: Flavonoid and Terpenoid Nitrogen-Containing Derivatives as ABC Transporter Modulators","volume":"25","author":"M F Gon\u00e7alves","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.isci.2025.114359_bib9","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1002\/1873-3468.13947","article-title":"The ABCG2\/BCRP transporter and its variants - from structure to pathology","volume":"594","author":"Sarkadi","year":"2020","journal-title":"FEBS Lett."},{"key":"10.1016\/j.isci.2025.114359_bib10","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd3028","article-title":"Membrane transporters in drug development","volume":"9","author":"International Transporter Consortium","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.isci.2025.114359_bib11","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/s41568-018-0005-8","article-title":"Revisiting the role of ABC transporters in multidrug-resistant cancer","volume":"18","author":"Robey","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.isci.2025.114359_bib12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2008.11.003","article-title":"ABCG2: a perspective","volume":"61","author":"Robey","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.isci.2025.114359_bib13","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12885-016-3038-y","article-title":"Cryptotanshinone activates AMPK-TSC2 axis leading to inhibition of mTORC1 signaling in cancer cells","volume":"17","author":"Chen","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.isci.2025.114359_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.624811","article-title":"Cryptotanshinone Inhibits ER\u03b1-Dependent and -Independent BCRP Oligomer Formation to Reverse Multidrug Resistance in Breast Cancer","volume":"11","author":"Ni","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.isci.2025.114359_bib15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10555-007-9042-6","article-title":"ABCG2: determining its relevance in clinical drug resistance","volume":"26","author":"Robey","year":"2007","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.isci.2025.114359_bib16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1208\/s12248-014-9668-6","article-title":"Role of the breast cancer resistance protein (BCRP\/ABCG2) in drug transport--an update","volume":"17","author":"Mao","year":"2015","journal-title":"AAPS J."},{"key":"10.1016\/j.isci.2025.114359_bib17","first-page":"698","article-title":"ABCG2 regulated by MAPK pathways is associated with cancer progression in laryngeal squamous cell carcinoma","volume":"4","author":"Xie","year":"2014","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.isci.2025.114359_bib18","article-title":"Increased JNK1 signaling pathway is responsible for ABCG2-mediated multidrug resistance in human colon cancer","volume":"7","author":"Zhu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2025.114359_bib19","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/s11626-009-9223-4","article-title":"Inhibition of p38 MAPK facilitates ex vivo expansion of skin epithelial progenitor cells","volume":"45","author":"Peng","year":"2009","journal-title":"In Vitro Cell. Dev. Biol. Anim."},{"key":"10.1016\/j.isci.2025.114359_bib20","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.ccell.2018.04.010","article-title":"Targeting p38\u03b1 Increases DNA Damage, Chromosome Instability, and the Anti-tumoral Response to Taxanes in Breast Cancer Cells","volume":"33","author":"C\u00e1novas","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2025.114359_bib21","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abm3687","article-title":"Phosphoproteomics of patient-derived xenografts identifies targets and markers associated with sensitivity and resistance to EGFR blockade in colorectal cancer","volume":"15","author":"Beekhof","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.isci.2025.114359_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3002227","article-title":"Cooperative activation of PDK1 and AKT by MAPK4 enhances cancer growth and resistance to therapy","volume":"21","author":"Han","year":"2023","journal-title":"PLoS Biol."},{"key":"10.1016\/j.isci.2025.114359_bib23","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/1878-0261.12419","article-title":"Hypoxia-inducible factor-2\u03b1 directly promotes BCRP expression and mediates the resistance of ovarian cancer stem cells to adriamycin","volume":"13","author":"He","year":"2019","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.isci.2025.114359_bib24","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.xphs.2018.10.043","article-title":"Modulation of Intestinal Transport and Absorption of Topotecan, a BCRP Substrate, by Various Pharmaceutical Excipients and Their Inhibitory Mechanisms of BCRP Transporter","volume":"108","author":"Sawangrat","year":"2019","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.isci.2025.114359_bib25","doi-asserted-by":"crossref","first-page":"4890","DOI":"10.1096\/fj.201902338RR","article-title":"ABCG2 requires a single aromatic amino acid to \u201cclamp\u201d substrates and inhibitors into the binding pocket","volume":"34","author":"Gose","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.isci.2025.114359_bib26","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1042\/BST20160014","article-title":"The multidrug transporter ABCG2: still more questions than answers","volume":"44","author":"Horsey","year":"2016","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.isci.2025.114359_bib27","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.drup.2016.05.001","article-title":"Overcoming ABC transporter-mediated multidrug resistance: Molecular mechanisms and novel therapeutic drug strategies","volume":"27","author":"Li","year":"2016","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.isci.2025.114359_bib28","doi-asserted-by":"crossref","first-page":"6887","DOI":"10.1007\/s00018-021-03901-y","article-title":"Multidrug efflux transporter ABCG2: expression and regulation","volume":"78","author":"Kukal","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.isci.2025.114359_bib29","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/ijc.20216","article-title":"Novel camptothecin analogues that circumvent ABCG2-associated drug resistance in human tumor cells","volume":"110","author":"Yoshikawa","year":"2004","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.isci.2025.114359_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102353","article-title":"p38 MAPK-dependent phosphorylation of transcription factor SOX2 promotes an adaptive response to BRAF inhibitors in melanoma cells","volume":"298","author":"Pietrobono","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.isci.2025.114359_bib31","article-title":"BIRB796, the inhibitor of p38 mitogen-activated protein kinase, enhances the efficacy of chemotherapeutic agents in ABCB1 overexpression cells","volume":"8","author":"He","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2025.114359_bib32","first-page":"1344","article-title":"Hyperactivation of MAPK induces loss of ERalpha expression in breast cancer cells","volume":"15","author":"Oh","year":"2001","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.isci.2025.114359_bib33","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s10555-023-10144-9","article-title":"Cancer cell plasticity, stem cell factors, and therapy resistance: how are they linked","volume":"43","author":"Fatma","year":"2024","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.isci.2025.114359_bib34","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cell.2010.02.027","article-title":"A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations","volume":"141","author":"Sharma","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.isci.2025.114359_bib35","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.trecan.2023.07.006","article-title":"Beyond matrix stiffness: targeting force-induced cancer drug resistance","volume":"9","author":"Kalli","year":"2023","journal-title":"Trends Cancer"},{"key":"10.1016\/j.isci.2025.114359_bib36","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1002\/hep.28149","article-title":"Mitogen-activated protein kinase kinase kinase 4 deficiency in intrahepatic cholangiocarcinoma leads to invasive growth and epithelial-mesenchymal transition","volume":"62","author":"Yang","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.isci.2025.114359_bib37","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/s41420-023-01463-5","article-title":"Drug-induced lactate confers ferroptosis resistance via p38-SGK1-NEDD4L-dependent upregulation of GPX4 in NSCLC cells","volume":"9","author":"Cheng","year":"2023","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.isci.2025.114359_bib38","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1158\/1535-7163.MCT-11-0684","article-title":"Inhibition of p38 MAPK-dependent excision repair cross-complementing 1 expression decreases the DNA repair capacity to sensitize lung cancer cells to etoposide","volume":"11","author":"Tsai","year":"2012","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.isci.2025.114359_bib39","doi-asserted-by":"crossref","first-page":"9448","DOI":"10.1021\/bi0497953","article-title":"Mutational analysis of ABCG2: role of the GXXXG motif","volume":"43","author":"Polgar","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.isci.2025.114359_bib40","doi-asserted-by":"crossref","first-page":"5251","DOI":"10.1021\/bi0521590","article-title":"Mutational studies of G553 in TM5 of ABCG2: a residue potentially involved in dimerization","volume":"45","author":"Polgar","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.isci.2025.114359_bib41","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1158\/0008-5472.CAN-06-3169","article-title":"Oligomerization domain of the multidrug resistance-associated transporter ABCG2 and its dominant inhibitory activity","volume":"67","author":"Xu","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2025.114359_bib42","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1111\/j.1349-7006.2010.01605.x","article-title":"BCRP\/ABCG2 confers anticancer drug resistance without covalent dimerization","volume":"101","author":"Shigeta","year":"2010","journal-title":"Cancer Sci."},{"key":"10.1016\/j.isci.2025.114359_bib43","doi-asserted-by":"crossref","first-page":"18337","DOI":"10.1074\/jbc.RA119.007758","article-title":"Intestinal breast cancer resistance protein (BCRP) requires Janus kinase 3 activity for drug efflux and barrier functions in obesity","volume":"294","author":"Mishra","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.isci.2025.114359_bib44","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1074\/jbc.M707773200","article-title":"The 44-kDa Pim-1 kinase phosphorylates BCRP\/ABCG2 and thereby promotes its multimerization and drug-resistant activity in human prostate cancer cells","volume":"283","author":"Xie","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.isci.2025.114359_bib45","doi-asserted-by":"crossref","first-page":"19781","DOI":"10.1074\/jbc.M310785200","article-title":"Characterization of oligomeric human half-ABC transporter ATP-binding cassette G2","volume":"279","author":"Xu","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.isci.2025.114359_bib46","first-page":"1","article-title":"Fluorescence resonance energy transfer (FRET) analysis demonstrates dimer\/oligomer formation of the human breast cancer resistance protein (BCRP\/ABCG2) in intact cells","volume":"1","author":"Ni","year":"2010","journal-title":"Int. J. Biochem. Mol. Biol."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225026203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225026203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T08:51:49Z","timestamp":1773996709000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004225026203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2589004225026203"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2025.114359","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"p38 inhibition restores chemosensitivity of tumor cells by disrupting oligomerized breast cancer resistance protein membrane trafficking","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2025.114359","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"114359"}}